电子增强,以减少血液型验证样本的拒绝
V Rakesh Sethapati1, Emily Morton2, Sashika Kilambi2
1Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Transfusion
|December 11, 2025
概括
通过防止标签打印直到初始类型和屏幕 (TNS) 样本采集后,电子增强显著减少了血型验证 (BTV) 拒绝. 这提高了患者的安全性和及时的血液产品可用性.
科学领域:
- 输血医学 输血医学
- 临床病理学 临床病理学
- 医疗信息学 医疗信息学
背景情况:
- 协会促进血液和生物疗法 (AABB) 标准要求对交叉匹配输血进行当前的类型和查 (TNS) 和血型验证 (BTV).
- BTV需要第二个,独立收集的血液样本,并重新确认患者身份.
- 政策要求在不同时间采集TNS和BTV样本;同时采集导致BTV被拒绝.
研究的目的:
- 描述一种旨在降低血型验证 (BTV) 拒绝率的电子增强.
- 为了提高输血前血液样本处理的效率和准确性.
主要方法:
- 实施电子健康记录 (EHR) 增强,防止BTV标签打印,直到TNS样本被记录为收集.
- 保证的BTV样本采集只有在初始的TNS样本验证后才能获得,强制执行独立的采集.
主要成果:
- 总体而言,BTV拒绝率从每月平均66个下降到实施后每月37个.
- 作为总样本排斥的百分比,BTV排斥率从每月的45%下降到2%.
结论:
- 一个简单的电子增强大大减少了BTV拒绝.
- 通过及时提供交叉匹配的血液制品,提高了患者安全.
- 减少了样本重新绘制的发生率,优化了实验室工作流程.
相关概念视频
Blood Typing
2.3K
Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
2.3K
Blood Transfusion and Agglutination
13.9K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
13.9K


